We focus on outcomes that matter, ensuring that every effort adds value and drives us forward at the speed of innovation.

Our strength lies in our diverse perspectives. By drawing on our collective experience and skills, we break new ground.

Collaboration is the engine of our success, driven by the synergy with our own team, our parent company, and the broader VC community.

Connections are our cornerstone.
We believe in nurturing relationships and investing in people who share our values.

We set the bar high, aiming to shape the future of care and positively impact patient outcomes by continually evolving and updating.

We support individual expertise and empower each other to act autonomously, driving
our collective success with confidence
and accountability.

ARCH Venture Partners invests in advanced technology companies and is one of the largest early-stage technology venture firms in the United States

In 2021, we partnered with Lumira Partners to create the Angelini Lumira Biosciences Fund (ALBF) to focus on early-stage companies operating in the CNS space in north America

Kurma is a major player in the funding of healthcare and biotechnology in Europe. We have co-invested with Kurma Partners in Argobio, a European startup studio, and continue to collaborate with Kurma’s team on new investment opportunities in digital health and life science.

CeMM is an interdisciplinary research institute of the Austrian Academy of Sciences committed to advancing the understanding of human diseases through basic and biomedical research

Imec's open accelerator program, offers tech startups pre-seed funding and tailored support to succeed and grow globally

VITA is the Digital Health Accelerator of CDP National Accelerators Network, born from an initiative of CDP Venture Capital Sgr together with Healthware Group and Accelerace.

A leading Italian incubator and accelerator supporting the launch and scale of digital and technology focused ventures.